Morgan Stanley »

Bridgebio Oncology Therapeut shares owned by Morgan Stanley

Quarter-by-quarter ownership of Bridgebio Oncology Therapeut (BBOT) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Bridgebio Oncology Therapeut

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Oncology Therapeut held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Oncology Therapeut by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2026-03-31 $388k 43k 8.95
2025-12-31 $180k 14k 12.52
2025-09-30 $10k 861 11.58

More positions owned by Morgan Stanley

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Tesla Motors (TSLA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)

View all positions for Morgan Stanley

Top funds holding Bridgebio Oncology Therapeut

Cormorant Asset Management
Deerfield Management Company
Omega Fund Management
EcoR1 Capital
Alphabet
Wellington Management Company
Enavate Sciences GP
Citadel Advisors
Novo A/S
BlackRock
Laurion Capital Management
Armistice Capital
Aisling Capital Management
Paradigm Biocapital Advisors
Vanguard Group

View all funds holding Bridgebio Oncology Therapeut